scholarly article | Q13442814 |
P356 | DOI | 10.1111/APA.12883 |
P698 | PubMed publication ID | 25474712 |
P50 | author | Andreas Ziegler | Q28322910 |
Axel von der Wense | Q49041043 | ||
German Neonatal Network | Q49041455 | ||
Michael Preuss | Q55712289 | ||
Claudia Roll | Q89757496 | ||
Wolfgang Göpel | Q90777532 | ||
Christian Wieg | Q90813426 | ||
Christoph Härtel | Q91923810 | ||
Angela Kribs | Q114512061 | ||
Matthias Vochem | Q114512068 | ||
Egbert Herting | Q114512069 | ||
Norbert Teig | Q114512074 | ||
German Neonatal Network (GNN) | Q114512076 | ||
Stefan Avenarius | Q114512077 | ||
Peter Groneck | Q114512078 | ||
Dirk Olbertz | Q114512081 | ||
Jürgen Wintgens | Q114512083 | ||
P2093 | author name string | Bernhard Roth | |
Ursula Weller | |||
P2860 | cites work | Bronchopulmonary dysplasia | Q28201380 |
Circulating mitochondrial DAMPs cause inflammatory responses to injury | Q29614470 | ||
Surfactant without intubation in preterm infants with respiratory distress: first multi-center data | Q33525079 | ||
Predictive value of umbilical artery pH in preterm infants | Q33706552 | ||
Increased risk for respiratory distress among white, male, late preterm and term infants. | Q36288816 | ||
Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation | Q36589813 | ||
Chronic lung disease after premature birth. | Q36995880 | ||
Bench-to-bedside review: Damage-associated molecular patterns in the onset of ventilator-induced lung injury | Q37973108 | ||
Innovation in surfactant therapy I: surfactant lavage and surfactant administration by fluid bolus using minimally invasive techniques | Q38039823 | ||
Avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia: a meta-analysis | Q38154381 | ||
Early surfactant in spontaneously breathing with nCPAP in ELBW infants--a single centre four year experience | Q44662545 | ||
Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial | Q46404873 | ||
Minimally-invasive surfactant therapy in preterm infants on continuous positive airway pressure | Q46555331 | ||
Less invasive surfactant administration in extremely preterm infants: impact on mortality and morbidity | Q46985339 | ||
Birth weight in relation to morbidity and mortality among newborn infants | Q47266890 | ||
Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. | Q51003917 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | breathing | Q9530 |
preterm infant | Q45051448 | ||
P304 | page(s) | 241-246 | |
P577 | publication date | 2015-03-01 | |
P1433 | published in | Acta Paediatrica | Q4676739 |
P1476 | title | Less invasive surfactant administration is associated with improved pulmonary outcomes in spontaneously breathing preterm infants | |
P478 | volume | 104 |
Q91566783 | A novel delivery system for supraglottic atomization allows increased lung deposition rates of pulmonary surfactant in newborn piglets |
Q26748643 | Can the preterm lung recover from perinatal stress? |
Q47842117 | Case-control study demonstrates that surfactant without intubation delayed mechanical ventilation in preterm infants |
Q39343569 | Delivery room interventions to prevent bronchopulmonary dysplasia in extremely preterm infants |
Q30831696 | Early skin-to-skin contact or incubator for very preterm infants: study protocol for a randomized controlled trial |
Q48025430 | Effects of different surfactant administrations on cerebral autoregulation in preterm infants with respiratory distress syndrome |
Q89970033 | Effects of less invasive surfactant administration (LISA) via a gastric tube on the treatment of respiratory distress syndrome in premature infants aged 32 to 36 weeks |
Q36220353 | European perspective on less invasive surfactant administration-a survey. |
Q93054651 | Fine Tuning Non-invasive Respiratory Support to Prevent Lung Injury in the Extremely Premature Infant |
Q41716215 | Golden hour of neonatal life: Need of the hour |
Q40729325 | Hydrocortisone use in ventilated extremely preterm infants decreased bronchopulmonary dysplasia with no effects on neurodevelopment after two years |
Q47770040 | Impact of Minimally Invasive Surfactant Therapy in Preterm Infants at 29-32 Weeks Gestation |
Q60303065 | Impact of surfactant administration through a thin catheter in the delivery room: A quality control chart analysis coupled with a propensity score matched cohort study in preterm infants |
Q91808202 | Less invasive surfactant administration (LISA): chances and limitations |
Q55064854 | Less invasive surfactant administration and complications of preterm birth. |
Q39010408 | Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis |
Q89755493 | Less invasive surfactant administration: best practices and unanswered questions |
Q28072037 | Metabolic Functions of the Lung, Disorders and Associated Pathologies |
Q35920248 | New modalities to deliver surfactant in premature infants: a systematic review and meta-analysis |
Q26746072 | Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development |
Q88632013 | Preventing Continuous Positive Airway Pressure Failure: Evidence-Based and Physiologically Sound Practices from Delivery Room to the Neonatal Intensive Care Unit |
Q36268039 | Surfactant administration via a thin endotracheal catheter during spontaneous breathing in preterm infants |
Q41054291 | Surfactant for Respiratory Distress Syndrome: New Ideas on a Familiar Drug with Innovative Applications |
Q38966506 | Surfactant instillation in spontaneously breathing preterm infants: a systematic review and meta-analysis |
Q47604126 | Survey shows large differences between the Nordic countries in the use of less invasive surfactant administration. |
Q33711647 | The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment. |
Q91010878 | The use of less invasive surfactant administration (LISA) in the United States with review of the literature |
Q57300315 | Transient intubation for surfactant administration in the treatment of respiratory distress syndrome in extremely premature infants |
Q88886226 | Treatment and outcome data of very low birth weight infants treated with less invasive surfactant administration in comparison to intubation and mechanical ventilation in the clinical setting of a cross-sectional observational multicenter study |
Q42376024 | Update of minimally invasive surfactant therapy |
Search more.